HK biotech firm Immuno Cure gears up for IPO with “$12m funding”
Immuno Cure, a Hong Kong-based biotech startup, is preparing for an IPO with a $12 million investment. Immuno Cure biotech, located in Hong Kong, has received $12 million from Gobi…
"We Report, You Decide"
Immuno Cure, a Hong Kong-based biotech startup, is preparing for an IPO with a $12 million investment. Immuno Cure biotech, located in Hong Kong, has received $12 million from Gobi…